Requirement of thymus-derived theta-positive lymphocytes for rejection of DNA virus (SV 40) tumors in mice.
D000818:Animals; D000918:Antibody Specificity; D000951:Antigens, Neoplasm; D001854:Bone Marrow Cells; D002460:Cell Line; D002469:Cell Separation; D003601:Cytotoxicity Tests, Immunologic; D004622:Embryo, Mammalian; D007106:Immune Sera; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D007668:Kidney; D008198:Lymph Nodes / Q000166:cytology; D051379:Mice; D008806:Mice, Inbred AKR; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D009500:Neutralization Tests; D009757:Nylons; D011828:Radiation Chimera; D013539:Simian virus 40 / Q000276:immunology*; D013154:Spleen / Q000166:cytology; D013601:T-Lymphocytes / Q000276:immunology*; D013934:Thymectomy; D013950:Thymus Gland / Q000166:cytology
D000951:Antigens, Neoplasm; D007106:Immune Sera; D009757:Nylons